Harrill1: sample sizes

Number of animals tested for each measure in this project, by strain and sex.       Cells with N < 5 are colored pink.

Harrill1 measure	Sex
bw_d1_ctrl   body weight day 1 , control group   39501	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
bw_d1_trt   body weight day 1 , treatment group   39502	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
bw_d4_ctrl   body weight day 4 , control   39503	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	4	4	4	4	4	4	4	4	4		4	4	4	4	4	4	4	4
	(M)
bw_d4_trt   body weight day 4 , isoniazid   39504	(F)	4	2	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	3	2	4	4	3	4	4		3	4	3	2	4	2	4	1
	(M)
liver_ctrl   liver weight , control   39505	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
liver_trt   liver weight , isoniazid   39506	(F)	4	2	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	3	2	4	4	3	4	4		3	4	4	4	4	2	4	3
	(M)
pct_liver_ctrl   liver weight as percentage of body weight , control   39507	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
pct_liver_trt   liver weight as percentage of body weight , isoniazid   39508	(F)	4	2	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	3	2	4	4	3	4	4		3	4	3	2	4	2	4	1
	(M)
spleen_ctrl   spleen weight , control   39511	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
spleen_trt   spleen weight , isoniazid   39512	(F)	4	2	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	3	2	4	4	3	4	4		3	4	4	4	4	2	4	3
	(M)
pct_spleen_ctrl   spleen weight as percentage of body weight , control   39513	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
pct_spleen_trt   spleen weight as percentage of body weight , isoniazid   39514	(F)	4	2	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	3	2	4	4	3	4	4		3	4	3	2	4	2	4	1
	(M)
ALT_ctrl   alanine transaminase (serum ALT) , control   39521	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
ALT_trt   alanine transaminase (serum ALT) , isoniazid   39522	(F)	4	2	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	3	2	4	4	3	4	4		3	4	3	2	4	2	3	1
	(M)
liver_CHOL_ctrl   hepatic cholesterol (CHOL) , control   39526	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
liver_CHOL_trt   hepatic cholesterol (CHOL) , isoniazid   39527	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3
	(M)
liver_TG_ctrl   hepatic triglycerides (TG) , control   39531	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
liver_TG_trt   hepatic triglycerides (TG) , isoniazid   39532	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	4	4	4	4	4	4	4	4	4	3	4	4	4	4	4	3
	(M)
lymphohistio_portal_ctrl   lymphohistiocytic, portal, multifocal infiltrate , control   39541	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
lymphohistio_portal_trt   lymphohistiocytic, portal, multifocal infiltrate , isoniazid   39542	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3
	(M)
microvesic_multi_ctrl   hepatocytic cytoplasmic, microvesiculation, multifocal , control   39546	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
microvesic_multi_trt   hepatocytic cytoplasmic, microvesiculation, multifocal , isoniazid   39547	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3
	(M)
microvesic_dif_ctrl   hepatocytic cytoplasmic, microvesiculation, diffuse , control   39551	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
microvesic_dif_trt   hepatocytic cytoplasmic, microvesiculation, diffuse , isoniazid   39552	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3
	(M)
hypertro_pan_ctrl   hepatocytic hypertrophy, panlobular, diffuse , control   39556	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4
	(M)
hypertro_pan_trt   hepatocytic hypertrophy, panlobular, diffuse , isoniazid   39557	(F)	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3	4	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3
	(M)